Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Fmr LLC

Fmr LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 1.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 10,822,224 shares of the medical equipment provider’s stock after selling 148,861 shares during the quarter. Fmr LLC’s holdings in Intuitive Surgical were worth $5,648,768,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter valued at $82,517,000. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This represents a 63.13 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 492 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $282,299.76. Following the transaction, the senior vice president now directly owns 4,056 shares in the company, valued at $2,327,251.68. This trade represents a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ISRG shares. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Truist Financial lowered their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Get Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $451.58 on Friday. The company’s 50 day moving average price is $545.18 and its 200 day moving average price is $532.64. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.